Bioprocessing LIMS
A LIMS configured for biopharmaceutical manufacturing — upstream and downstream process sampling, in-process controls, and bioanalytical testing, all under 21 CFR Part 11.
What a Bioprocessing LIMS Actually Does
A bioprocess doesn't produce a handful of QC samples at the end — it generates a stream of them, all the way through. Every fermentation and cell-culture stage upstream, every purification step downstream, and every in-process control in between produces samples that have to be pulled on time, tested, and checked against limits before the process moves on. A bioprocessing LIMS is the system that keeps that stream under control.
It ties each sample to its process step and bioreactor stage, captures results and instrument data, gates the next step on in-process control limits, and assembles the whole batch's process history into a record you can trace and defend — with the audit trail and electronic signatures GMP demands.
Built for the Bioprocess Workflow
The capabilities a biologics process lab needs beyond routine QC.
Fermentation & Cell Culture
Stage- and time-based sampling plans tied to bioreactors, with results tracked across the run.
Purification Steps
Sampling and testing through each purification stage, with yield and purity tracked step to step.
In-Process Controls
IPC limits that gate progression, so an out-of-limit result stops the next step instead of surfacing later.
Potency & Purity Assays
Bioanalytical, cell-based and immunoassay results captured with methods, controls and acceptance criteria.
21 CFR Part 11
Electronic signatures, tamper-evident audit trail, and ALCOA+ controls across the whole batch history.
Direct Data Capture
Instrument interfacing so analytical data flows into the record without manual transcription.
Where Bioprocess Samples Come From
The stages and tests below are typical; the exact list depends on the product and the process.
| Stage | Typical samples and tests | What a LIMS keeps traceable |
|---|---|---|
| Cell bank and seed train | Viability, identity, sterility and mycoplasma testing | Every sample traces to a cell bank vial and lot |
| Production bioreactor | Viable cell density, viability, pH, glucose and lactate, titer, by time point | Each reading belongs to a run, a vessel and a sampling time |
| Harvest and clarification | Bioburden, turbidity, titer | Harvest results link back to the whole upstream run |
| Purification | Protein concentration, purity (SEC or HPLC), residual host-cell protein and DNA, step yield | Yield and purity are comparable step to step and lot to lot |
| Drug substance and product release | Identity, potency, purity, endotoxin, sterility, appearance | The release record pulls the full process history with it |
The Biologics Quality Guidelines a Bioprocess Record Supports
Biologics are governed by a family of ICH quality guidelines and by EU GMP Annex 2. The results a bioprocessing LIMS holds are the evidence behind each of them:
- ICH Q5A(R2): viral safety evaluation of products made from human or animal cell lines.
- ICH Q5C: stability testing of biotechnological and biological products, which a stability LIMS schedules and tracks.
- ICH Q5D: derivation and characterisation of the cell substrates used for production.
- ICH Q5E: comparability of biological products after a manufacturing process change.
- ICH Q6B: specifications, test procedures and acceptance criteria for biological products.
- EU GMP Annex 2: manufacture of biological active substances and medicinal products for human use.
Bioprocessing on the CORPEX Platform
CORPEX brings bioprocess sampling, in-process control and bioanalytical testing together on one compliant core, alongside our BioLIMS for biochemical laboratories and StabLIMS for stability programs. For teams that also run SAP or another ERP, results and dispositions flow through our LIMS–SAP integration, so the bioprocess record and the business record stay in step.
See a Bioprocessing LIMS Built for GMP
Talk to a CORPEX specialist about configuring a LIMS for your upstream, downstream and bioanalytical workflows.
Request a ConsultationBioprocessing LIMS — Frequently Asked Questions
What is a bioprocessing LIMS?
A LIMS configured for biopharmaceutical manufacturing. It manages the sampling and testing around a bioprocess — upstream fermentation and cell culture, downstream purification, in-process controls, and release testing — linking process samples to results, specifications and the batch record with a full audit trail under 21 CFR Part 11 and GMP.
How is it different from a standard LIMS?
The core is the same, but a bioprocessing configuration adds sampling tied to process steps and bioreactor stages, in-process control limits that gate the next step, stage-based sampling plans, and trending across a batch's process history — handling the sample volume and timing of a live bioprocess rather than one-off QC samples.
Does it support 21 CFR Part 11 and GMP?
Yes. It provides electronic signatures, a tamper-evident audit trail, and ALCOA+ data-integrity controls compliant with FDA 21 CFR Part 11, with validation (IQ/OQ/PQ) support as part of implementation.
Can it handle bioanalytical testing?
Yes. Bioanalytical assays — potency, purity, cell-based and immunoassays — are captured with their methods, controls and acceptance criteria, results tied to the process sample and instrument data captured directly, keeping a defensible chain from raw data to the reported result.